Article info

Download PDFPDF
S112 Long-term safety and efficacy of ivacaftor in paediatric patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation

Authors

Citation

Davies J, Robertson S, Cooke J, et al
S112 Long-term safety and efficacy of ivacaftor in paediatric patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation

Publication history

  • First published November 15, 2016.
Online issue publication 
September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.